META
Meta Platforms, Inc.
META has the edge over RDCM overall, supported by lower modeled downside and stronger modeled upside.
RDCM
RADCOM Ltd.
RDCM trails on the overall score without a compensating advantage in the available component scores.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
RDCM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Strong |
RDCM's balance sheet is currently strong, and its profitability and cash flow are stable, but its revenue is under pressure.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
RDCM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $7.88 | -26% |
| Forward | 24x | $10.61 | — |
| Fair | 25x | $10.65 | +0.3% |
| Current | 25x | $10.61 | — |
| Expensive | 41x | $17.28 | +63% |
Historical ranges are pointers, not guarantees.
RDCM has the edge over META in the historical PE scenario, which offers more potential upside but is not a forecast.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
META has the edge over RDCM on the outlook, with more favorable valuation and earnings expectations.
RDCM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect RDCM's earnings and revenue to decline, with profitability weakening.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META earned $29.32 per share over the past year, up 30% from the year before.
RDCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.43 | +3.3% |
| Q2 2026 | $0.42 | -28% |
| Q1 2026 | $0.75 | +39% |
| Q4 2025 | $0.72 | +64% |
| Q3 2025 | $0.65 | +38% |
| Q2 2025 | $0.58 | +87% |
| Q1 2025 | $0.54 | +116% |
| Q4 2024 | $0.44 | +83% |
| Q3 2024 | $0.47 | +571% |
RDCM has the edge over META on earnings, with more consistent year-over-year improvement.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over RDCM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over RDCM on profitability, with a higher operating margin.
RDCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.8M | -33% |
| Q1 2026 | $18.6M | +12% |
| Q4 2025 | $18.9M | +16% |
| Q3 2025 | $18.4M | +16% |
| Q2 2025 | $17.7M | +19% |
| Q1 2025 | $16.6M | +17% |
| Q4 2024 | $16.3M | +16% |
| Q3 2024 | $15.8M | +20% |
RDCM's revenue has held roughly level: $12M last quarter, down 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -32% | -42 points |
| Q1 2026 | 12% | +2.9 points |
| Q4 2025 | 14% | +6.2 points |
| Q3 2025 | 13% | +5.5 points |
| Q2 2025 | 9.8% | +3.9 points |
| Q1 2025 | 8.8% | +11 points |
| Q4 2024 | 8.1% | -2.1 points |
| Q3 2024 | 7.6% | +17 points |
RDCM's operating margin was −32% last quarter, down 42 points from the same quarter a year ago, near the bottom of its range since 2019.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over RDCM on cash flow, with more consistent year-over-year improvement.
RDCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
RDCM's free cash flow was $0 over the past year, against $0 the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over RDCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
RDCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -235K shares |
| 1 year | +0.7% | +125K shares |
| 3 years | +7.5% | +1.2M shares |
| 5 years | +19% | +2.7M shares |
| Available history | +22% | +3M shares |
RDCM has 17M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
RDCM hasn't bought back shares in the past year.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
RDCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.2x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | -1.9x | Net Cash |
RDCM has the edge over META on leverage, with a lower net debt burden relative to earnings.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
RDCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 35.0 | Neutral |
RDCM's weekly RSI is 44 (neutral) and its Stochastic is 35 (neutral).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META has the edge over RDCM on valuation relative to its sector.
RDCM PE vs Communication Services Sector
| Metric | RDCM | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 16x | 53% above |
| PE % | 48 | 26 | 22 pts above |
RDCM is trading at 25x earnings, a 53% premium to the Communication Services sector's median of 16x, though its recent earnings include one-off gains.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
RDCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 3.4% above |
| 20 week MA | $11.0 | 3.4% below |
| 50 week MA | $12.2 | 13% below |
| 100 week MA | $12.6 | 16% below |
| 200 week MA | $11.1 | 4.7% below |
RDCM has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 4.7% below its 200-week average.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over RDCM on returns for 2026, with the stronger performance.
RDCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.43 | $10.8 | +28% |
| 2021 | $10.8 | $11.6 | +8.1% |
| 2022 | $11.6 | $10.3 | -12% |
| 2023 | $10.3 | $8.06 | -22% |
| 2024 | $8.06 | $11.9 | +48% |
| 2025 | $11.9 | $13.6 | +14% |
| 2026 YTD | $13.6 | $10.6 | -22% |
RDCM has finished higher in four of the last six years. It's down 22% so far in 2026.